Sinopharm Hyundai announced that its holding subsidiary dacarbazine for injection passed the generic drug consistency evaluation.
国药现代：控股子公司药品注射用达卡巴嗪通过仿制药一致性评价
Sinopharm Hyundai: The holding subsidiary's injectable dacarbazine passed the generic drug consistency evaluation
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.